mpoellmann
- Jan 13
- 1 min read

Capio recieves funding from the KORIL foundation, launches new study

Capio Biosciences and BioView have launched a $2.18M project to advance the use of liquid biopsy for head and neck cancer. The project is supported with a $874,000 grant from the Korea-Israel (KORIL) Industrial R&D Foundation.

Recent Posts

See All

Capio Biosciences Korea will expand to Gangwon Technopark

Capio Biosciences Korea is one of four companies selected to receive support from Hongcheon-gun to open a second office within the Hongcheon National Antibody Cluster within Gangwon Technopark. The lo

Capio Biosciences was highlighted in the Wisconsin State Journal

Capio Biosciences, BioView to Explore Integration of Circulating Tumor Cell Technologies